In an important development that could increase vaccine availability in India, Johnson & Johnson, the only manufacturer with a single-dose Covid-19 vaccine, has informed the Indian regulator that it will soon begin bridging clinical trials in the country. According to government sources, J&J will soon begin trials that will pave the way for its vaccine […]
